HRT Financial
BOLD icon

HRT Financial’s Boundless Bio BOLD Stock Holding History

HRT Financial’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
+116,288
New +$179K ﹤0.01% 3102
2025
Q3 		– Sell
-27,509
Closed -$27K – 3824
2025
Q2 		$27K Buy
+27,509
New +$36.5K ﹤0.01% 2371

Other funds holding BOLD

Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

HRT Financial's BOLD Position: Q2 2026 in Review

HRT Financial opened a new position in Boundless Bio (BOLD) in Q2 2026: 116,288 shares worth $290K. The stake represents ﹤0.01% of the portfolio and ranks #3102 among its holdings. This is a return to the name: HRT Financial previously reported a position in BOLD as recently as Q2 2025.

HRT Financial first reported a position in BOLD in Q2 2025 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • HRT Financial held 116,288 shares of Boundless Bio worth $290K as of Q2 2026.
  • Boundless Bio was a new HRT Financial position in Q2 2026.
  • Boundless Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3102 holding.
  • HRT Financial first reported a position in Boundless Bio in Q2 2025 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.